James O Armitage Cardiff Oncology, Inc. (CRDF) insider trading activity
James O Armitage is Director of Cardiff Oncology, Inc.. Currently has a direct ownership of 14,490 shares of CRDF, which is worth approximately $45,208. The most recent transaction as insider was on Mar 19, 2021, when has been sold 4,000 shares (Common Stock) at a price of $10.82 per share, resulting in proceeds of $43,280. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14.5K
0%
3M change
0%
12M change
Total Value Held
$45,208
JOA
James O Armitage
Director
San Diego, CA